Prostate Cancer - Results from #23260

ASCO 2013 - Poster: Hematologic safety of radium-223 dichloride in castration-resistant prostate cancer (CRPC) patients with bone metastases from the phase III ALSYMPCA trial June 12, 2013

ASCO 2013 - Poster: CA184-095: A randomized, double-blind, phase 3 trial to compare the efficacy of ipilimumab vs placebo in asymptomatic or minimally symptomatic patients with metastatic chemotherapy-naïve castration-resistant prostate cancer June 12, 2013

Treatment for Localized Prostate Cancer June 12, 2013

Image-guided method for TLD-based in vivo rectal dose verification with endorectal balloon in proton therapy for prostate cancer - Abstract June 11, 2013

Investigation of (90)Y-avidin for prostate cancer brachytherapy: A dosimetric model for a phase I–II clinical study - Abstract June 11, 2013

Bone turnover markers in patients with prostate carcinoma: Influence of sex steroids levels - Abstract June 11, 2013

Anxiety status and its relationship with general health related quality of life among prostate cancer patients in two university hospitals in Kuala Lumpur, Malaysia - Abstract June 11, 2013

Sociodemographic and health-related predictors of self-reported mammogram, faecal occult blood test and prostate specific antigen test use in a large Australian study - Abstract June 11, 2013

Management of high-risk prostate cancer: Radiation therapy and hormonal therapy - Abstract June 11, 2013

The effect of antibiotherapy on PSA levels and prostate biopsy results in patients with PSA levels 2.5-10 ng/mL - Abstract June 11, 2013

Pathologic outcomes in men with low-risk and very low-risk prostate cancer: Implications on the practice of active surveillance - Abstract June 11, 2013

Differences in self-reported outcomes of open prostatectomy patients and robotic prostatectomy patients in an international web-based survey - Abstract June 11, 2013

ASCO 2013 - Poster: Impact of prior docetaxel (D) on sipuleucel-T (sip-T) product parameters in PROCEED patients June 11, 2013

ASCO 2013 - Poster: A randomized, phase II trial of sipuleucel-T with concurrent or sequential abiraterone acetate plus prednisone in metastatic castrate-resistant prostate cancer (mCRPC) June 11, 2013

ASCO 2013 - Poster: Randomized phase II trial evaluating the optimal sequencing of sipuleucel-T and androgen deprivation therapy (ADT) in patients with biochemically recurrent prostate cancer (BRPC): Immune results June 11, 2013

ASCO 2013 - Poster: Correlation between baseline variables and survival in the radium-223 dichloride phase III ALSYMPCA trial with attention to total ALP changes June 10, 2013

ASCO 2013 - Podcast: Correlation between baseline variables and survival in the radium-223 dichloride phase III ALSYMPCA trial with attention to total ALP changes June 10, 2013

Recrudescent prostate cancer with a low serum PSA level and a high serum CEA level treated with docetaxel : A case report - Abstract June 10, 2013

Low-dose-rate or high-dose-rate brachytherapy in treatment of prostate cancer - between options - Abstract June 10, 2013

ASCO 2013 - Slide Presentation: CRPC: The place of novel agents focused on the androgen axis June 10, 2013

Page 1164 of 1450